Indicators

Latest News about BIIB

Recent news which mentions BIIB

< Previous 1 2 3 4 5 6 7 8 9

...

A Closer Look at 21 Analyst Recommendations For Biogen

March 05, 2024

Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits

March 04, 2024

1 Wall Street Analyst Thinks Biogen Stock Is Going to $311. Is It a Buy Around $223?

March 02, 2024

Top Stocks Not Named Nvidia You Need To Know About In 2024: Here's What Investors Think About Them (Wall Street Vs. Reddit)

February 29, 2024

Biogen Unusual Options Activity

February 29, 2024

3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024

February 22, 2024

Peering Into Biogen's Recent Short Interest

February 19, 2024

From Zero to Hero: 7 Stock Losers That Could Turn Things Around in 2024

February 19, 2024

7 Contrarian Biotech Stocks to Consider Amid Sector Weakness

February 15, 2024

Biogen Could Engage In $1B-$2B Deals To Fill Revenue Shortfall Gaps, Analyst Says

February 14, 2024

Citigroup To Rally Over 19%? Here Are 10 Top Analyst Forecasts For Wednesday

February 14, 2024

Biogen (BIIB) Q4 2023 Earnings Call Transcript

February 13, 2024

Markets Tumble, VIX Up 8% On Hot Inflation Data, Dollar, Yields Jump As Traders Unwind Rate Cut Bets: What's Driving Markets Tuesday?

February 13, 2024

Why Is Biogen Stock Trading Lower On Tuesday?

February 13, 2024

Breaking Down Biogen: 8 Analysts Share Their Views

February 13, 2024

Nasdaq, S&P 500 Set For Weaker Open As Traders Keep Eyes Peeled On Inflation Data: Analyst Flags Key CPI Report Item To Watch

February 13, 2024

Earnings Scheduled For February 13, 2024

February 13, 2024

Looking At Biogen's Recent Unusual Options Activity

February 12, 2024

3 Millionaire-Maker Stocks to Buy While the Gettin’ Is Good

February 12, 2024

Here's How Much You Would Have Made Owning Biogen Stock In The Last 20 Years

February 09, 2024

7 Biotech Stocks Fighting America’s Deadliest Diseases

February 08, 2024

Biogen Gives Up On Aduhelm Efforts After Two Years Of Controversial FDA Accelerated Approval For Alzheimer's, Shifts Focus On Newer Medicines

January 31, 2024

NeuroSense's (NASDAQ: NRSN) ALS Drug Candidate Shows Promise In Recent Phase 2b Trial; More Milestones To Come In 2024

January 29, 2024

AT&T To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Thursday

January 25, 2024

Slow Market Penetration For Biogen's Another Alzheimer's Drug: UBS Highlights Risks, Forecasts

January 24, 2024

Critical Insights From Biogen Analyst Ratings: What You Need To Know

January 24, 2024

Highlights From the 2024 JPMorgan Health Care Conference

January 22, 2024

These Could Be the Biggest Nasdaq-100 Winners in 2024, According to Wall Street

January 18, 2024

Evolving Landscape For Alzheimer's Blood Tests Gains Momentum Amid Inaccuracy Concerns

January 12, 2024

$1000 Invested In This Stock 20 Years Ago Would Be Worth $6,100 Today

January 11, 2024

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.